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Abstract – BALB/c nude mice 6 weeks old were 
inoculated with glioma C6 cell-line and the efficacy 
of the different amount of Etanidazole-discs and 
Taxol-microspheres was 
investigated. Poly (D,L-lactic-co-glycolic acid) 
(PLGA) was used as the main encapsulating 
polymer and polyethylene glycol was added to 
increase the porosity. The 1% drug loading 
microspheres of each drug were produced by spray 
drying and the discs were obtained by compressing 
the Etanidazole-microspheres. Intra-tumoral 
injection followed by irradiation resulted in high 
systemic dosage and thus systemic toxicity. Tumors 
grown for 6 days, 9 days and 16 days were 
implanted with 0.5 mg or 1.0 mg or 1.5 mg of the 
drug. A radiation dosage of 2 Gy each time for a 
number of times was given for animals implanted 
with Etanidazole and no irradiation was given for 
animals implanted with Taxol. Increasing the 
number of doses clearly decreased the rate of 
tumor growth. The increase in the amount of drug 
on smaller sized tumors controlled the tumor 
better and there was agglomeration of the 
microspheres resulting in deviation of release 
profile of the drug as compared to the in vitro 
studies. It was observed that 1.0 mg of Taxol given 
to a tumor grown for 6 days was able to suppress 
the tumor for a total period of approximately two 
months and no tumor resurrection was observed 
during the second month. 
